Overview
SCIENTIFIC SCORE
Moderately Effective
Based on 2 Researches
8.5
USERS' SCORE
Medium or Average
Based on 17 Reviews
6.7
Supplement Facts
Serving Size: 2 Veg Capsules
Amount Per Serving
%DV
MSM (Methylsulfonylmethane)
2 g (2,000 mg)
*
Top Medical Research Studies
8
We dived into how adherence to acute migraine medications influences migraine severity and patient satisfaction. Over three months, participants diligently recorded their migraine experiences in daily diaries.
With 337 adults participating, the findings showed that those using migraine-specific medication (MSM), especially when pain was milder, reported the best outcomes. This included less daily disability and greater satisfaction with their medication.
Our results suggest that starting treatment with MSM may lead to a better quality of life for migraine sufferers.
With 337 adults participating, the findings showed that those using migraine-specific medication (MSM), especially when pain was milder, reported the best outcomes. This included less daily disability and greater satisfaction with their medication.
Our results suggest that starting treatment with MSM may lead to a better quality of life for migraine sufferers.
Read More
9
Erenumab reduces migraine medication use
We explored how erenumab impacts the use of acute headache medication, especially migraine-specific medications (MSM). The study analyzed data from two major clinical trials involving patients with episodic migraine (EM) and chronic migraine (CM). Participants received either erenumab or placebo over a set period, allowing us to compare medication usage accurately.
Our findings indicate that treatment with erenumab led to a significant decrease in the number of days patients used acute headache medications, particularly in those relying on MSM. This reduction was observed in both episodic and chronic migraine patients, suggesting that erenumab not only helps manage migraines but may also help mitigate the need for additional acute treatment.
Overall, these results highlight the potential benefits of erenumab in addressing not just the frequency of migraines but also reducing dependence on medications traditionally used for acute migraine relief.
Our findings indicate that treatment with erenumab led to a significant decrease in the number of days patients used acute headache medications, particularly in those relying on MSM. This reduction was observed in both episodic and chronic migraine patients, suggesting that erenumab not only helps manage migraines but may also help mitigate the need for additional acute treatment.
Overall, these results highlight the potential benefits of erenumab in addressing not just the frequency of migraines but also reducing dependence on medications traditionally used for acute migraine relief.
Read More
Most Useful Reviews
9
Eased headaches
5 people found this helpful
I've found that this supplement helps with inflammation, particularly my stiff shoulders and associated headaches. After taking one tablet daily, my shoulder stiffness has improved.
Read More
9
Headache relief
2 people found this helpful
This product has been great for treating my migraines and is much cheaper here than in Brazil. It acts as an anti-inflammatory for headaches and joint pain. My doctor recommended it and I have had a positive response.
Read More
9
Helped headaches
A friend of mine has constant headaches, and this medication helps her tremendously. I will be ordering more for her benefit!
Read More
Medical Researches
SCIENTIFIC SCORE
Moderately Effective
Based on 2 Researches
8.5
- All Researches
9
Erenumab reduces migraine medication use
We explored how erenumab impacts the use of acute headache medication, especially migraine-specific medications (MSM). The study analyzed data from two major clinical trials involving patients with episodic migraine (EM) and chronic migraine (CM). Participants received either erenumab or placebo over a set period, allowing us to compare medication usage accurately.
Our findings indicate that treatment with erenumab led to a significant decrease in the number of days patients used acute headache medications, particularly in those relying on MSM. This reduction was observed in both episodic and chronic migraine patients, suggesting that erenumab not only helps manage migraines but may also help mitigate the need for additional acute treatment.
Overall, these results highlight the potential benefits of erenumab in addressing not just the frequency of migraines but also reducing dependence on medications traditionally used for acute migraine relief.
Our findings indicate that treatment with erenumab led to a significant decrease in the number of days patients used acute headache medications, particularly in those relying on MSM. This reduction was observed in both episodic and chronic migraine patients, suggesting that erenumab not only helps manage migraines but may also help mitigate the need for additional acute treatment.
Overall, these results highlight the potential benefits of erenumab in addressing not just the frequency of migraines but also reducing dependence on medications traditionally used for acute migraine relief.
Read More
8
We dived into how adherence to acute migraine medications influences migraine severity and patient satisfaction. Over three months, participants diligently recorded their migraine experiences in daily diaries.
With 337 adults participating, the findings showed that those using migraine-specific medication (MSM), especially when pain was milder, reported the best outcomes. This included less daily disability and greater satisfaction with their medication.
Our results suggest that starting treatment with MSM may lead to a better quality of life for migraine sufferers.
With 337 adults participating, the findings showed that those using migraine-specific medication (MSM), especially when pain was milder, reported the best outcomes. This included less daily disability and greater satisfaction with their medication.
Our results suggest that starting treatment with MSM may lead to a better quality of life for migraine sufferers.
Read More
User Reviews
USERS' SCORE
Medium or Average
Based on 17 Reviews
6.7
- All Reviews
- Positive Reviews
- Negative Reviews
9
Eased headaches
5 people found this helpful
I've found that this supplement helps with inflammation, particularly my stiff shoulders and associated headaches. After taking one tablet daily, my shoulder stiffness has improved.
Read More
9
Headache relief
2 people found this helpful
This product has been great for treating my migraines and is much cheaper here than in Brazil. It acts as an anti-inflammatory for headaches and joint pain. My doctor recommended it and I have had a positive response.
Read More
9
Helped headaches
A friend of mine has constant headaches, and this medication helps her tremendously. I will be ordering more for her benefit!
Read More
0
Migraine worsened
15 people found this helpful
Migraine Alert! I wanted to warn others prone to migraines that this product triggered a three-day migraine after I began it. I took the recommended dosage initially but found that those sensitive to headaches should introduce it slowly. After stopping for two days, my head improved, and I resumed with a single pill (1mg). The bottle suggests 2mg three times daily. I plan to take 1mg daily for a week to see if the headache returns. It helped my knee joint pain but caused severe exhaustion and persistent headaches. After discontinuing, I felt much better. Not a good experience at all for me.
Read More
8.5
Effective for headaches
2 people found this helpful
My daughter primarily drinks it. It appears effective for menstrual cramps and headaches, so I've ceased taking Loxonin.
Read More
Frequently Asked Questions
7.5
Less shoulder headaches
After suffering from stiff shoulders for many years, I started taking this supplement. My headaches, related to the stiff shoulders, have decreased significantly since I began using it.
0
No effect on headaches
1 people found this helpful
I purchased this nutritional supplement for my torn ankle ligaments. However, despite the positive reviews, it caused headaches with no significant benefit. I think consulting with a doctor is advisable.
9
Eased headaches
5 people found this helpful
I've found that this supplement helps with inflammation, particularly my stiff shoulders and associated headaches. After taking one tablet daily, my shoulder stiffness has improved.
0
Headaches from product
I bought two boxes for my knee issues but developed sharp headaches after a week of use. Stopping the pills halted the headaches, but they returned upon resuming. I'm unsure what to do.
7.5
Knee head pain relief
1 people found this helpful
After several years of taking this supplement, my husband and I have noticed a significant reduction in knee headaches. I also supplement it with vitamin C for additional support.
9
Headache relief
2 people found this helpful
This product has been great for treating my migraines and is much cheaper here than in Brazil. It acts as an anti-inflammatory for headaches and joint pain. My doctor recommended it and I have had a positive response.
8
Headache-free
1 people found this helpful
I’m very pleased with the fast delivery and quality packaging. I’ve noticed significant benefits after just 10 days of taking one capsule daily. My headaches have stopped, I feel more energetic, and my mood has greatly improved.
9
Erenumab reduces migraine medication use
We explored how erenumab impacts the use of acute headache medication, especially migraine-specific medications (MSM). The study analyzed data from two major clinical trials involving patients with episodic migraine (EM) and chronic migraine (CM). Participants received either erenumab or placebo over a set period, allowing us to compare medication usage accurately.
Our findings indicate that treatment with erenumab led to a significant decrease in the number of days patients used acute headache medications, particularly in those relying on MSM. This reduction was observed in both episodic and chronic migraine patients, suggesting that erenumab not only helps manage migraines but may also help mitigate the need for additional acute treatment.
Overall, these results highlight the potential benefits of erenumab in addressing not just the frequency of migraines but also reducing dependence on medications traditionally used for acute migraine relief.
Our findings indicate that treatment with erenumab led to a significant decrease in the number of days patients used acute headache medications, particularly in those relying on MSM. This reduction was observed in both episodic and chronic migraine patients, suggesting that erenumab not only helps manage migraines but may also help mitigate the need for additional acute treatment.
Overall, these results highlight the potential benefits of erenumab in addressing not just the frequency of migraines but also reducing dependence on medications traditionally used for acute migraine relief.
8
We dived into how adherence to acute migraine medications influences migraine severity and patient satisfaction. Over three months, participants diligently recorded their migraine experiences in daily diaries.
With 337 adults participating, the findings showed that those using migraine-specific medication (MSM), especially when pain was milder, reported the best outcomes. This included less daily disability and greater satisfaction with their medication.
Our results suggest that starting treatment with MSM may lead to a better quality of life for migraine sufferers.
With 337 adults participating, the findings showed that those using migraine-specific medication (MSM), especially when pain was milder, reported the best outcomes. This included less daily disability and greater satisfaction with their medication.
Our results suggest that starting treatment with MSM may lead to a better quality of life for migraine sufferers.
References
- Tepper SJ, Ashina M, Reuter U, Hallström Y, Broessner G, et al. Reduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical trials. J Headache Pain. 2021;22:81. doi:10.1186/s10194-021-01292-w
- Seng EK, Robbins MS, Nicholson RA. Acute migraine medication adherence, migraine disability and patient satisfaction: A naturalistic daily diary study. Cephalalgia. 2017;37:955. doi:10.1177/0333102416663459
